Stem cells and gliomas: past, present, and future

Journal of Neuro-Oncology

Volumn 119, Issue 3, 2014, Pages 547-555

  Germano, Isabelle M ^a   Binello, Emanuela ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell therapy; Clinical trials; Gene therapy; Glioblastoma; Glioma stem cells; High grade glioma; Stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD133 ANTIGEN; FLUOROURACIL; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; STAGE SPECIFIC EMBRYO ANTIGEN 1; TEMOZOLOMIDE;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DEDIFFERENTIATION; CHEMOSENSITIZATION; EMBRYONIC STEM CELL; GLIOBLASTOMA; GLIOMA; GLIOMA STEM CELL; HUMAN; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PLURIPOTENT STEM CELL; RADIOSENSITIZATION; REVIEW; STEM CELL; STEM CELL GENE THERAPY; TERATOMA; TUMOR RECURRENCE; ANIMAL; BRAIN NEOPLASMS; CLINICAL TRIAL (TOPIC); PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION;

ANIMALS; BRAIN NEOPLASMS; CARCINOGENESIS; CLINICAL TRIALS AS TOPIC; GLIOMA; HUMANS; NEOPLASTIC STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84918797885     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1498-y     Document Type: Review

References (61)

1. Altman J, Das GD (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124:319–335
2. Goldman SA, Nottebohm F (1983) Neuronal production, migration, and differentiation in a vocal control nucleus of the adult female canary brain. Proc Natl Acad Sci USA 80:2390–2394
3. Johansson CB, Clarke DL, Momma S et al (1999) Identification of neural stem cell in the adult mammalian central nervous system. Cell 96:25–34
4. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737
5. Virchow R (1863) Die krankhaften Geschwuelste. Hirshwald, Berlin
6. Germano IM, Swiss V, Casaccia P (2010) Primary brain tumors, neural stem cells, and brain tumor cancer cells: where is the link? Neuro-pharmacology 58(6):903–910
7. Schiffer D, Giordana MT, Mauro A et al (1986) Immunohistochemical demonstration of vimentin in human cerebral tumors. Acta Neuropath 70:209–219
8. Masui K, Suzuki SO, Torisu R et al (2010) Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation. Glia 58:1050–1065
9. Liu C, Sage JC, Miller MR et al (2011) Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146:209–221
10. Kondo T, Raff M (2000) Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289:1754–1757
11. Parsons DW, Jones S, Zhang X (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812
12. Dougherty JD, Fomchenko EI, Akuffo AA et al (2012) Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Res 72:4856–4868
13. Rosemblum ML, Gerosa M, Dougherty DV et al (1982) Age-related chemosensitivity of stem cells from human malignant brain tumors. Lancet 1:885–887
14. Reya T, Morrison SJ, Clarke MF et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
15. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
16. Lacks DR, Masterman-Smith M, Visnyei K et al (2009) Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27:980–987
17. Beier D, Hau P, Proescholdt M et al (2007) CD133+ and CD133− glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010–4015
18. Ogden AT, Waziri AE, Lochhead RA et al (2008) Identification of A2B5+ CD133− tumor-initiating cells in adult human gliomas. Neurosurgery 62:505–515
19. Mao XG, Zhang X, Xue XY et al (2009) Brain tumor stem-like cells identified by neural stem cell marker CD15. Transl Oncol 2:247–257
20. Rasper M, Schafer A, Piontek G et al (2010) Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neurooncology 12:1024–1033
21. Thon N, Damianoff K, Hegeman J et al (2010) Presence of pluripotent CD133 + cells correlates with malignancy of gliomas. Mol Cell Neurosci 43:51–59
22. Zeppernick F, Ahmadi R, Campos B et al (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14:123–129
23. Pallini R, Ricci-Vitiani L, Banna GL et al (2008) Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14:8205–8212
24. Kim KJ, Lee KH, Kim HS et al (2011) The presence of stem cells marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 31:494–502
25. Liu DY, Ren CP, Yuan XR et al (2012) ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma. J Clin Neurosci 19:1700–1705
26. Strojnik T, Rosland GV, Sakariassen PO (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68:133–144
27. Elsir T, Edqvist PH, Carlson J et al (2014) A study of embryonic stem cell-related proteins in human astrocytomas: identification of nanog as a predictor of survival. Int J Cancer 134:1123–1131
28. Zhang M, Song T, Yang L et al (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27:85. doi:10.1186/1756-9966-27-85
29. Binello E, Germano IM (2011) Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci 102:1958–1966
30. Binello E, Mormone E, Emdad L, Kothari H, Germano IM (2014) Characterization of fenofibrate-mediate anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells. J Neurooncol 117:225–234
31. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760
32. Raso A, Vecchio D, Cappelli E et al (2012) Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol 22:677–688
33. Cheng L, Wu Q, Huang Z et al (2011) L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J 30:800–813
34. Lim YC, Roberts TL, Day BW et al (2012) A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells. Mol Cancer Ther 11:1863–1872
35. Persano L, Pistollato F, Rampazzo E et al (2012) BMP2 sensitizes glioblastoma stem-like cells to temozolomide by affecting HIF-1α stability and MGMT expression. Cell Death Dis 3:e412. doi:10.1038/cddis.2012.153
36. Siebzehnrubl FA, Silver DJ, Tugertimur B et al (2013) The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 5:1196–1212
37. Ciceroni C, Bonelli M, Mastrantoni E et al (2013) Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas. Cell Death Differ 20:396–407
38. Happold C, Roth P, Silginer M et al (2014) Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells. Mol Cancer Ther 13(4):948–961
39. Osuka S, Sampetream O, Shimizu T et al (2013) IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells. Stem Cells 31:627–640
40. Kang KB, Zhu C, Wong YL et al (2012) Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PT signaling, accompanied by inhibition of DNA double-strand break repair. Int J Radiat Oncol Biol Phys 83:e43–e52. doi:10.1016/j.ijrobp.2011.11.037
41. Martin V, Sanchez-Sanchez AM, Herrera F et al (2013) Melatonin-induced methylation of the ABCG2/BRCP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. Br J Cancer 108:2005–2012
42. Yang YP, Chen Y, Chiou GY et al (2012) Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA 145 with cationic polyurethane-short branch PEI. Biomaterials 33:1462–1476
43. Asutkhar S, Velpula KK, Chetty C et al (2012) Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. Oncotarget 3:1439–1454
44. Hardee ME, Marciscano AE, Medina-Ramirez CM et al (2012) Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer Res 72:119–129
45. Shi L, Wan Y, Sun G et al (2012) Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. Neuromol Med 14:303–316
46. Germano IM, Binello E (2009) Gene therapy for adjuvant treatment of malignant gliomas: from bench to bedside. J Neurooncol 93:79–87
47. Germano IM, Uzzaman M, Keller G (2008) Gene delivery by embryonic stem cells for malignant gliomas: hype or hope? Cancer Biol Ther 7:81–87
48. Germano IM, Binello E (2012) Stem cells as vehicles for the treatment of high-grade gliomas. Neurooncology 14:256–265
49. Nakamura K, Ito Y, Kawano Y et al (2009) Antitumor effect of genetically engineered mesenchymal stem cells in rat glioma model. Gene Ther 11:1155–1164
50. Benveniste R, Keller G, Germano IM (2005) Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: differentiation and allotransplantation into the mouse brain. J Neurosurg 103:115–123
51. Aboody KS, Najbauer J, Metz MZ et al (2013) Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies. Sci Transl Med 5:18459
52. Amariglio N, Hirshberg A, Scheithauer BW et al (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PloS Med 6:1000029
53. Spaeth EL, Dembinski JL, Sasser AK et al (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4:e4992
54. Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557–563
55. Akimoto K, Kimura K, Nagano M et al (2013) Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev 22:1370–1386
56. Emdad L, Qadeer ZA, D’Souza SL et al (2012) Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev 21:404–4120
57. Germano IM, Emdad L, Qader Z et al (2010) Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis, radiosensitization, and overcomes temozolomide resistance in malignant gliomas. Cancer Gene Ther 17(9):664–674
58. Uzzaman M, Keller G, Germano IM (2007) Enhanced pro-apoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on temozolomide-resistant glioma cells. J Neurosurg 106:646–651
59. Uzzaman M, Keller G, Germano IM (2009) In vivo gene delivery by embryonic stem cell-derived astrocytes for malignant gliomas. Neuro-oncology 11:102–108
60. Mandal K, Rossi DJ (2013) Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 8:568–572
61. Mormone E, D’Souza S, Alexeeva V, Bederson MM, Germano IM (2014) "Footprint-free" human induced pluripotent stem cell-derived astrocytes for in vivo cell-based therapy. Stem Cells Dev. doi:10.1089/scd.2014.0151